ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.49%
S&P ASX All Technology
3,102.60
0.47%
Brent Oil
79.395
0.00%
US Dollar vs AUD
1.51653
-0.06%
Bitcoin
69,411.51
0.11%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Biogen Inc (0R1B) Share Price

0R1B Biogen Inc

277.67
0.00 (0.00%)
07 Jun 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 915
Bid Price
Ask Price
News -
Day High

Low
277.67

52 Week Range

High
277.67

Day Low
Share Name Share Symbol Market Stock Type
Biogen Inc 0R1B London Ordinary Share
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 277.67 10:00:00
Open Price Low Price High Price Close Price Previous Close
277.67 277.67
Trades Shares Traded Average Volume 52 Week Range
54 915 - 277.67 - 277.67
Last Trade Type Quantity Price Currency
03:57:58 O 5 US$ 226.80 USD

Biogen Inc Financials
Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
32.66B 144.90M - 9.84B 1.16B 8.01 28.13
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Biogen News
Date Time Source News Article
31/5/202406:51GlobeNewswire Inc.Biogen Receives European Commission Approval for..
22/5/202421:30GlobeNewswire Inc.Biogen Bolsters Late-Stage Pipeline, Expands Immunology..
16/5/202421:30GlobeNewswire Inc.Biogen and Ionis Announce Topline Phase 1/2 Study Results of..
15/5/202409:33GlobeNewswire Inc.Eisai Initiates Rolling Biologics License Application to US..
26/4/202406:05GlobeNewswire Inc.Biogen Receives Positive CHMP Opinion for TOFIDENCE™..
06/3/202423:30UK RegulatoryNew Biomarker Data Add Further Evidence Supporting the..
05/3/202408:15UK RegulatoryBiogen Highlights New Data at the International Conference..
23/2/202423:00UK RegulatoryBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
13/2/202408:06UK RegulatoryBiogen Received European Commission Approval for SKYCLARYS®..
31/1/202423:30UK RegulatoryBiogen to Realign Resources for Alzheimer's Disease..
19/12/202323:30GlobeNewswire Inc.Centralized Marketing Authorizations of Generic Versions of..
16/12/202301:05GlobeNewswire Inc.CHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..

Historical 0R1B Price Data
Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week277.67277.67277.67277.671,4870.000.00%
1 Month277.67277.67277.67277.671,6160.000.00%
3 Months277.67277.67277.67277.672,0900.000.00%
6 Months277.67277.67277.67277.672,3190.000.00%
1 Year277.67277.67277.67277.673,3680.000.00%
3 Years277.67277.67277.67277.674,9890.000.00%
5 Years277.67277.67277.67277.674,7450.000.00%

Your Recent History

LSE
0R1B
Biogen
LSE
49DP
Mound Fin.4 4aa
BIT
UC0Q36
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved